Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel;  NCI Clinical and Translational Exploratory/Developmental Studies.                    

*Date:*                         September 14, 2018.                    

*Time:*                         8:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         The Westin Arlington Gateway,  801 North Glebe Road, Arlington, VA 22203.                    

*Contact Person:*                         Robert S. Coyne, Ph.D.,  Scientific Review Officer,  Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W236, Bethesda, MD 20892-9750, 240-276-7684,                         *coyners@mail.nih.gov*.                    

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel;  SEP-7: NCI Clinical and Translational R21 and Omnibus R03.                    

*Date:*                         September 27, 2018.                    

*Time:*                         7:30 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852.                    

*Contact Person:*                         Saejeong J. Kim, Ph.D.,  Scientific Review Officer,  Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W640, Bethesda, MD 20892-9750, 240-276-5179,                         *saejeong.kim@nih.gov*.                    

*Name of Committee:*                         National Cancer Institute Initial Review Group,  Subcommittee J—Career Development.                    

*Date:*                         October 11-12, 2018.                    

*Time:*                         5:00 p.m. to 4:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda Marriott Suites, 6711 Democracy Boulevard Bethesda, MD 20817.                    

*Contact Person:*                         Tushar Deb, Ph.D.,  Scientific Review Officer,  Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W624, Bethesda, MD 20892-9750, 240-276-6132,                         *tushar.deb@nih.gov*.                    

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel;  Innovative Molecular and Cellular Analysis Technologies (IMAT).                    

*Date:*                         October 19, 2018.                    

*Time:*                         8:30 a.m. to 5:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 2E908, Rockville, MD 20850.                    

*Contact Person:*                         Yasuko Furumoto, Ph.D.,  Scientific Review Officer,  Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W634, Bethesda, MD 20892-9750, 240-276-5287,                         *yasuko.furumoto@nih.gov*.                    

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; R25 Review.                    

*Date:*                         October 24, 2018.                    

*Time:*                         1:00 p.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W110, Rockville, MD 20850 (Telephone Conference Call).                    

*Contact Person:*                         Robert E. Bird, Ph.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W110, Bethesda, MD 20892-9750, 240-276-6344,                         *birdr@mail.nih.gov*.                    

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Innovative Molecular Analysis Technologies (IMAT).                    

*Date:*                         November 1, 2018.                    

*Time:*                         11:00 a.m. to 2:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W634, Rockville, MD 20850 (Telephone Conference Call).                    

*Contact Person:*                         Yasuko Furumoto, Ph.D.,  Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W634, Bethesda, MD 20892-9750, 240-276-5287,                         *yasuko.furumoto@nih.gov*.                    

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; UH2/UH3 Review.                    

*Date:*                         November 7, 2018.                    

*Time:*                         1:00 p.m. to 4:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W110, Rockville, MD 20850 (Telephone Conference Call).                    

*Contact Person:*                         Robert E. Bird, Ph.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W110, Bethesda, MD 20892-9750, 240-276-6344,                         *birdr@mail.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: August 1, 2018.

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2018-16784 Filed 8-6-18; 8:45 am]

BILLING CODE 4140-01-P